Medicare Enrolled
Dr. Rebecca Roedersheimer, MD
Urology Physician · Cincinnati, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Roedersheimer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Roedersheimer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Roedersheimer
Dr. Rebecca Roedersheimer is an urology physician in Cincinnati, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Roedersheimer performed 9,926 Medicare services across 2,335 unique beneficiaries.
Between the years covered by Open Payments, Dr. Roedersheimer received a total of $12,735 from 57 pharmaceutical and/or device companies across 585 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Roedersheimer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in OH
$12,735 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,926
Medicare services
Top 3% in OH for urology physician
2,335
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~522 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 5,351 | $2 | $9 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,200 | $0 | $1 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
885 | $3 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
461 | $91 | $248 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
302 | $65 | $204 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
208 | $8 | $52 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
171 | $45 | $206 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
162 | $8 | $39 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
161 | $7 | $94 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
113 | $8 | $105 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
112 | $66 | $468 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
112 | $8 | $105 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
103 | $114 | $394 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
65 | $126 | $1,098 |
| Insertion of temporary bladder tube | 59 | $34 | $192 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
59 | $54 | $623 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
48 | $51 | $350 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
43 | $8 | $32 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
43 | $113 | $1,333 |
| Simple change of bladder tube | 37 | $73 | $266 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
33 | $15 | $77 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
28 | $100 | $318 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
23 | $78 | $412 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
21 | $39 | $112 |
| PSA test (prostate cancer screening) | 20 | $18 | $71 |
| Electronic analysis of implanted neurostimulator with complex programming This procedure involves the electronic evaluation of an implanted neurostimulator generator. It includes complex programming of spinal cord or peripheral nerve stimulators. |
20 | $30 | $269 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
19 | $302 | $2,299 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $79 | $295 |
| Injection of implant material into bladder or urethra A procedure where implant material is injected beneath the lining of the bladder and/or urethra using an endoscope. |
13 | $145 | $946 |
| Insertion of peripheral or gastric neurostimulator generator A surgical procedure to implant the pulse generator device for a neurostimulator system. The generator is placed under the skin to deliver electrical impulses to nerves or the stomach. |
13 | $65 | $667 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
13 | $62 | $149 |
| Endoscopic removal of kidney or ureter stone A procedure to remove or manipulate a stone in the kidney or ureter using an endoscope. The endoscope is a thin, lighted tube inserted into the body to visualize and treat the stone. |
12 | $272 | $1,648 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
14.6% medium
84.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,735
Total received (2018-2024)
Avg $1,819/year across 7 years
Top 13% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
585
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,260 (96.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$475 (3.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,388
2023
$3,710
2022
$1,558
2021
$2,119
2020
$946
2019
$1,093
2018
$922
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$521
ABBVIE INC.
$500
Sumitomo Pharma America, Inc.
$280
Dendreon Pharmaceuticals LLC
$133
Janssen Biotech, Inc.
$118
UROGEN PHARMA, INC.
$114
Astellas Pharma US Inc
$100
Axonics, Inc.
$84
COLOPLAST CORP
$83
PFIZER INC.
$80
Calyxo, Inc.
$68
ACCORD HEALTHCARE, INC.
$56
Novartis Pharmaceuticals Corporation
$55
Bayer Healthcare Pharmaceuticals Inc.
$55
Olympus America Inc.
$29
Boston Scientific Corporation
$22
Smith+Nephew, Inc.
$21
PROGENICS PHARMACEUTICALS, INC.
$20
BIOTISSUE HOLDINGS INC.
$18
KARL STORZ Endoscopy-America
$15
IMMUNITYBIO, INC.
$15
Top 3 companies account for 54.5% of 2024 payments
All-time payments by company (2018-2024) ›
Coloplast Corp
$2,322
Astellas Pharma US Inc
$1,653
Axonics, Inc.
$1,649
Medtronic, Inc.
$1,236
Medtronic USA, Inc.
$641
ABBVIE INC.
$533
Sumitomo Pharma America, Inc.
$397
Teleflex LLC
$308
Dendreon Pharmaceuticals LLC
$267
COLOPLAST CORP
$242
Boston Scientific Corporation
$241
AbbVie Inc.
$227
Ferring Pharmaceuticals Inc.
$219
Axonics Modulation Technologies, Inc.
$218
UROVANT SCIENCES INC
$179
UROGEN PHARMA, INC.
$177
PFIZER INC.
$148
NeoTract Inc.
$146
TOLMAR Pharmaceuticals, Inc.
$140
Janssen Biotech, Inc.
$137
Myovant Sciences Inc.
$130
Bayer Healthcare Pharmaceuticals Inc.
$127
UroGen Pharma, Inc.
$124
Merck Sharp & Dohme LLC
$120
Allergan, Inc.
$119
Calyxo, Inc.
$86
Antares Pharma, Inc.
$85
ACCORD HEALTHCARE, INC.
$77
Endo Pharmaceuticals Inc.
$74
Caldera Medical, Inc
$56
Novartis Pharmaceuticals Corporation
$55
Olympus America Inc.
$45
Renovia Inc
$41
EMD Serono, Inc.
$39
ConvaTec Inc.
$36
Wilmington Medical Supply, Inc.
$35
DENTSPLY IH Inc.
$35
Tolmar, Inc.
$30
180 Medical, Inc.
$29
Bayer HealthCare Pharmaceuticals Inc.
$29
PORTOLA PHARMACEUTICALS, INC.
$23
Hollister Incorporated
$23
Sun Pharmaceutical Industries Inc.
$22
Progenics Pharmaceuticals, Inc.
$22
Smith+Nephew, Inc.
$21
PROGENICS PHARMACEUTICALS, INC.
$20
BIOTISSUE HOLDINGS INC.
$18
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
Rochester Medical Corporation
$15
KARL STORZ Endoscopy-America
$15
IMMUNITYBIO, INC.
$15
ABC Home Medical Supply, Inc.
$13
Avadel Specialty Pharmaceuticals, LLC
$12
Amgen Inc.
$12
Mission Pharmacal Company
$12
AbbVie, Inc.
$12
Clarus Therapeutics Inc.
$11
Top 3 companies account for 44.2% of all-time payments
Associated products mentioned in payments ›
AMS 700 · ANKTIVA · AVEED · Altis · Axonics · Axonics r-SNM System · BAVENCIO · BEVYXXA · BOTOX · Bulkamid · CAMCEVI · CEREC · CLENPIQ · CONTINENCE CARE · CVAC ASPIRATION SYSTEM · Desara · ELIGARD · ERLEADA · FIRMAGON · GEMTESA · GENERAL PELVIC ORGAN PROLAPSE · GENTLECATH · INTERSTIM · Isiris aStent Removal Device · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LithoVue · LoFric · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · PROVENGE · PYLARIFY · Percutaneous Tract Kit · Peristeen · Prolia · Restorelle · SPEEDICATH · STRAVIX · SpeediCath · UROLIFT · Uribel · UroLift · UroLift System · VaPro Plus Pocket · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA · iTIND System · leva Pelvic Floor Trainer
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
84
Per 100K population
10.1
County median income
$70,816
Nearest hospital
MERCY HEALTH - WEST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Roedersheimer is a mixed practice specialist, with above-average Medicare volume (top 3% in OH), with low-engagement industry engagement in the top 13% of OH peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Roedersheimer experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Roedersheimer performed 5,351 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Roedersheimer receive payments from pharmaceutical companies?
Yes. Dr. Roedersheimer received a total of $12,735 from 57 companies across 585 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Roedersheimer's costs compare to other urology physicians in Cincinnati?
Dr. Roedersheimer's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Roedersheimer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Cincinnati
Browse urology physicians in Cincinnati ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology